GlassScriptPhysician profile
Eszter Varga
NPI 1215368949
$1,279.67
in general payments reported to CMS, 2019-2025
20 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.57 · 2022: $152 · 2023: $333 · 2024: $372 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $186.54 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $166.89 | 2022-2025 | Qelbree, Qelbree |
| Abbott Laboratories | $164.98 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $117.66 | 2022-2025 | Mounjaro, Trulicity |
| Ironshore Pharmaceuticals INC. | $96.77 | 2024 | |
| Exact Sciences Corporation | $69.40 | 2023-2025 | Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $65.10 | 2025 | Jornay Pm |
| Pfizer INC. | $60.40 | 2023-2025 | |
| Novo Nordisk INC | $58.42 | 2022-2025 | Wegovy |
| Alk-Abello, INC | $56.36 | 2025 | Neffy, Odactra, Grastek |
| Merck Sharp & Dohme LLC | $46.20 | 2023-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Astrazeneca Pharmaceuticals LP | $41.96 | 2024 | Airsupra |
| Corium, LLC | $29.51 | 2023 | Azstarys |
| Sobi, INC | $25.25 | 2021 | |
| Kyowa Kirin, INC. | $17.62 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16.32 | 2021 | |
| Glaxosmithkline, LLC. | $16.09 | 2025 | Shingrix, Arexvy |
| Ardelyx, INC. | $15.82 | 2024 | Ibsrela |
| Tris Pharma INC | $15.20 | 2025 | Onyda Xr |
| Cranial Technologies, INC | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eszter Varga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.